amitriptyline hydrochloride: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
amitriptyline hydrochloride: clinical details
Prescribing considerations
- Assess suicide and overdose risk.
- Review cardiac disease, QT-prolonging medicines, electrolyte disturbance and anticholinergic burden.
- Use particular caution with epilepsy, urinary retention, prostatic enlargement, narrow-angle glaucoma, diabetes, hyperthyroidism, hepatic impairment and older age.
- Persistent childhood enuresis requires specialist expertise, exclusion of organic pathology and a pretreatment ECG.
- Avoid abrupt discontinuation after established use.
Contraindications and cautions
- Hypersensitivity to amitriptyline or a formulation excipient.
- Recent myocardial infarction, heart block, cardiac rhythm disorder or coronary insufficiency.
- Concurrent monoamine oxidase inhibitor treatment.
- Severe liver disease.
- Use for nocturnal enuresis in children younger than 6 years.
Monitoring
- Clinical response, adverse effects, suicidal thinking and behavioural change.
- Pulse, blood pressure and cardiac symptoms; consider ECG and electrolytes where cardiac risk is present.
- Anticholinergic effects, falls, cognition and postural hypotension, particularly in older adults.
- Blood glucose where diabetes is present.
- Serum sodium if symptoms suggest hyponatraemia.
Clinical pharmacology
A tertiary-amine tricyclic antidepressant that inhibits serotonin and noradrenaline reuptake and has anticholinergic, sedative and ion-channel-blocking properties. It is metabolised in the liver, including through CYP2D6 and CYP2C19, to active nortriptyline.
Formulation and product differences
- Selected products include film-coated tablets and oral solutions.
- The selected tablet contains lactose.
- Selected oral solutions contain methyl and propyl parahydroxybenzoate and require an appropriate oral measuring device.
- Concentration and excipients differ between oral solutions; identify the exact product clearly.
amitriptyline hydrochloride preparations and strengths
Oral solution
Route: Oral
Strengths: 10 mg/5 mL, 25 mg/5 mL, 50 mg/5 mL
Tablet
Route: Oral
Strengths: 10 mg, 25 mg, 50 mg
amitriptyline hydrochloride interactions
Check prescribed, pharmacy and herbal products with a pharmacist or prescriber. Important interactions include:
Monoamine oxidase inhibitors
The combination is contraindicated because it can cause serious serotonin toxicity and cardiovascular effects.
Opioids, including tramadol
Sedation and breathing problems may increase. Tramadol also increases risks of seizures, serotonin syndrome and opioid toxicity.
SSRIs and CYP2D6 inhibitors, including fluoxetine, paroxetine and bupropion
They may increase exposure or serotonergic adverse effects.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.